Basic Information
Diabetogen Biosciences, Inc. discovers and designs new drugs for the treatment of autoimmune diseases. The company’s developed compounds include peptides, antibodies, and natural products with proven efficacy in animal models of Type 1 diabetes.
Diabetogen Biosciences, Inc.
London,Ontario,Canada
15~50 people
January 01, 2000
--
--